Faculty

Vijay K. Ramanan, M.D., Ph.D.

Clinical Studies

ALSENLITE: An Open-label Pilot Study of Senolytics for Alzheimer's Disease (ALSENLITE) Rochester, Minn.
The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib plus Quercetin treatment in adults with early stage but symptomatic Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

ALZ-NET: Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Rochester, Minn.
The purpose of this study is to collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheimer's disease therapies.